Annual EBIT
-$104.18 M
-$98.41 M-1707.06%
31 December 2023
Summary:
Humacyte annual earnings before interest & taxes is currently -$104.18 million, with the most recent change of -$98.41 million (-1707.06%) on 31 December 2023. During the last 3 years, it has fallen by -$39.85 million (-61.96%). HUMA annual EBIT is now -1707.06% below its all-time high of $2.44 million.HUMA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$36.76 M
+$17.38 M+32.10%
30 September 2024
Summary:
Humacyte quarterly earnings before interest & taxes is currently -$36.76 million, with the most recent change of +$17.38 million (+32.10%) on 30 September 2024. Over the past year, it has dropped by -$12.23 million (-49.86%). HUMA quarterly EBIT is now -183.59% below its all-time high of $43.98 million, reached on 31 December 2021.HUMA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$144.37 M
-$12.23 M-9.26%
30 September 2024
Summary:
Humacyte TTM earnings before interest & taxes is currently -$144.37 million, with the most recent change of -$12.23 million (-9.26%) on 30 September 2024. Over the past year, it has dropped by -$61.49 million (-74.19%). HUMA TTM EBIT is now -458.27% below its all-time high of $40.30 million, reached on 30 September 2022.HUMA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HUMA EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1707.1% | -49.9% | -74.2% |
| 3 y3 years | -62.0% | -21.1% | -76.5% |
| 5 y5 years | - | - | - |
HUMA EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1707.1% | at low | -183.6% | +32.1% | -458.3% | at low |
| 5 y | 5 years | -1707.1% | at low | -183.6% | +32.1% | -458.3% | at low |
| alltime | all time | -1707.1% | at low | -183.6% | +32.1% | -458.3% | at low |
Humacyte EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$36.76 M(-32.1%) | -$144.37 M(+9.3%) |
| June 2024 | - | -$54.15 M(+80.0%) | -$132.14 M(+33.5%) |
| Mar 2024 | - | -$30.08 M(+28.7%) | -$98.99 M(-5.0%) |
| Dec 2023 | -$104.18 M(+1707.1%) | -$23.38 M(-4.7%) | -$104.18 M(+25.7%) |
| Sept 2023 | - | -$24.53 M(+16.8%) | -$82.88 M(+1.1%) |
| June 2023 | - | -$21.00 M(-40.5%) | -$81.99 M(+262.2%) |
| Mar 2023 | - | -$35.27 M(+1594.9%) | -$22.64 M(+292.6%) |
| Dec 2022 | -$5.76 M | -$2.08 M(-91.2%) | -$5.76 M(-114.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$23.64 M(-161.6%) | $40.30 M(+20.0%) |
| June 2022 | - | $38.36 M(-308.5%) | $33.58 M(-261.7%) |
| Mar 2022 | - | -$18.40 M(-141.8%) | -$20.76 M(-6.2%) |
| Dec 2021 | -$22.13 M(-65.6%) | $43.98 M(-244.9%) | -$22.13 M(-72.9%) |
| Sept 2021 | - | -$30.36 M(+89.9%) | -$81.78 M(+19.2%) |
| June 2021 | - | -$15.98 M(-19.1%) | -$68.63 M(+30.4%) |
| Mar 2021 | - | -$19.77 M(+26.1%) | -$52.65 M(+60.1%) |
| Dec 2020 | -$64.32 M | -$15.67 M(-8.9%) | -$32.88 M(+91.1%) |
| Sept 2020 | - | -$17.21 M | -$17.21 M |
FAQ
- What is Humacyte annual earnings before interest & taxes?
- What is the all time high annual EBIT for Humacyte?
- What is Humacyte annual EBIT year-on-year change?
- What is Humacyte quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Humacyte?
- What is Humacyte quarterly EBIT year-on-year change?
- What is Humacyte TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Humacyte?
- What is Humacyte TTM EBIT year-on-year change?
What is Humacyte annual earnings before interest & taxes?
The current annual EBIT of HUMA is -$104.18 M
What is the all time high annual EBIT for Humacyte?
Humacyte all-time high annual earnings before interest & taxes is $2.44 M
What is Humacyte annual EBIT year-on-year change?
Over the past year, HUMA annual earnings before interest & taxes has changed by -$98.41 M (-1707.06%)
What is Humacyte quarterly earnings before interest & taxes?
The current quarterly EBIT of HUMA is -$36.76 M
What is the all time high quarterly EBIT for Humacyte?
Humacyte all-time high quarterly earnings before interest & taxes is $43.98 M
What is Humacyte quarterly EBIT year-on-year change?
Over the past year, HUMA quarterly earnings before interest & taxes has changed by -$12.23 M (-49.86%)
What is Humacyte TTM earnings before interest & taxes?
The current TTM EBIT of HUMA is -$144.37 M
What is the all time high TTM EBIT for Humacyte?
Humacyte all-time high TTM earnings before interest & taxes is $40.30 M
What is Humacyte TTM EBIT year-on-year change?
Over the past year, HUMA TTM earnings before interest & taxes has changed by -$61.49 M (-74.19%)